Beijing News Shell Financial News On December 11, Nutrichem Bio (833819BJ) announced that in order to ensure that the construction results of the fund-raising project better meet the requirements of the company's development plan, the company fully considered the actual use of the raised funds and the implementation status of the fund-raising project, and extended the time of the "transformation and upgrading of pesticide raw drug products and the comprehensive utilization of by-product sperm and phenol comprehensive utilization project" to December 31, 2024 under the condition that the investment purpose and investment scale of the raised funds do not change.
According to the announcement, Nutrichem Bio's fund-raising project was originally planned to reach the scheduled usable state on December 31, 2023, and the total committed investment of the raised funds was about 41.4 billion yuan, and the current project investment progress is 6923%。
Nutrichem Bio said that the main reason for the postponement of the fundraising project is that "from 2020 to 2022, due to the impact of external factors such as regional conflicts, extreme weather, and global public health events, the materials**, logistics and transportation, and material procurement required for the fundraising project are limited, and the overall progress of the project is slow." From the fourth quarter of 2022, affected by the previous large-scale procurement by customers in overseas markets and the high inventory of channels, there have been wait-and-see, delayed procurement and destocking on the market side, which has exacerbated the phased surplus and led to the continuous decline of pesticides as a whole. In line with the principle of prudence and maximization of benefits, the company adjusted the product layout and production plan according to market demand, and adjusted the construction progress of the fundraising project according to the overall production plan, and the overall progress of the project was slightly delayed. ”
Regarding the impact of the postponement of the fundraising project on the company, Nutrichem Bio said that the postponement of the fundraising project is a prudent decision made by the company according to the actual implementation of the project, and the project extension only involves changes in the progress of the fundraising project, and does not change the construction content, implementation subject, purpose of the raised funds and the total amount of investment, and there is no disguised change in the investment direction of the raised funds and damage to the interests of shareholders, and will not have a substantial impact on the implementation of the fundraising project.
Edited by Huang Xinyu.
Proofread by Liu Baoqing.